(Q37183749)

English

The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy

scientific article published on 08 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

esophageal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Kang Guo

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ling Cai

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Yu Zhang

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jian-Fei Zhu

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tie-Hua Rong

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Peng Lin

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Chong-Li Hao

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Wu-Ping Wang

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Zhe Li

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lan-Jun Zhang

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

8 May 2012

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Chinese Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

399-408

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Neoadjuvant strategies for the treatment of locally advanced esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Multimodality therapy for esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

6 September 2017

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

14 September 2017

Considerations of treatment standardization from the procession of NCCN guideline of esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Impact of neoadjuvant therapy of perioperative morbidity in patients with esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

3 September 2018

Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777510

4 December 2018

Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of Life During Neoadjuvant Treatment and After Surgery for Resectable Esophageal Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esophageal and esophagogastric junction cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22572013

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.5732/CJC.011.10406

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37183749&oldid=2139652984"